<?xml version="1.0" ?>
<document id="f7bb1f005066cb4930f83cde4cdc1ff3fe411def">
  <chunk id="f7bb1f005066cb4930f83cde4cdc1ff3fe411def.c0" text="Overview of the 3rd isirv-Antiviral Group Conference - advances in clinical management"/>
  <chunk id="f7bb1f005066cb4930f83cde4cdc1ff3fe411def.c1" text="This review highlights the main points which emerged from the presentations and discussions at the 3rd isirv-Antiviral Group Conference -advances in clinical management. The conference covered emerging and potentially pandemic influenza viruses and discussed novel/pre-licensure therapeutics and currently approved antivirals and vaccines for the control of influenza. Current data on approved and novel treatments for non-influenza respiratory viruses such as MERS-CoV, respiratory syncytial virus (RSV) and rhinoviruses and the challenges of treating immunocompromised patients with respiratory infections was highlighted.">
    <entity charOffset="585-607" id="f7bb1f005066cb4930f83cde4cdc1ff3fe411def.c1.e0" ontology_id="HP_0011947" text="respiratory infections" type="phenotype"/>
  </chunk>
</document>
